FDA reviewing Vytorin cholesterol drug
455038
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol drug Vytorin after a study showed it was no better than a generic in preventing the build-up of fatty plaque.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
733605
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc  and Schering-Plough's  cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
171695
What you hear before taking prescription drugs versus what you learn afterward may make you feel like a lab rat. Before: Bayer&#39;s Baycol lowers cholesterol.
438501
Here's what a newly approved drug looks like.
159888
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way it monitors safety risks associated with medicines already  on the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
546608
Federal advisers today and tomorrow will consider whether the Food and Drug Administration should approve Merck &amp; Co.'s bid to make Mevacor the first of a class of hot-selling cholesterol-lowering drugs called statins to be sold over the counter.
228790
Merck & Co.'s Inc.'s cholesterol-lowering drug Mevacor would benefit patients who take it properly over the counter, but an advisory panel should weigh the risks if people take higher-than-recommended doses, U.S. regulatory staff said in documents released on Wednesday.
336778
U.S. FDA staff reviewers on Tuesday  said data on a new non-Hodgkin's lymphoma drug made by Inex  Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc. may be  unreliable due to the trial's structure and size.
432275
The US Food and Drug Administration (FDA) today approved FOSRENOL(R) (lanthanum carbonate), a new non-calcium, non-aluminium phosphate binder that reduces high serum phosphate levels in patients with end-stage renal disease (ESRD).
42115
The chief executive of Merck &amp; Co on Wednesday said negative media coverage of a clinical trial of the company's blockbuster Vytorin cholesterol drug has unfairly overlooked benefits of the medicine.
190069
The FDA issues a health advisory for a top Pfizer drug.
587421
Investors kept their eye on makers of generic pharmaceuticals Monday with news that Mylan Laboratories Inc. received Food and Drug Administration approval to market a generic version of a Novartis AG hypertension
321830
The FDA grants a speedy review for Millennium's lead drug.
211731
The Food and Drug Administration on Thursday ordered a review of all prevention studies involving drugs such as Celebrex and Bextra, which have been associated with increased risk of heart problems. The agency also urged the public to limit use of over-the-counter pain medications.
268173
A U.S. Food and Drug Administration  preliminary analysis found a level of heart-attack risk with  GlaxoSmithKline Plc&#39;s  diabetes drug Avandia  similar to what was reported in a study earlier this week, the  agency confirmed on Friday.
115250
A high-dose regimen of Merck&#39;s cholesterol drug Zocor offered no conclusive benefits over a low-cholesterol diet and a lower dose of Zocor in preventing a recurrence of cardiac events